A biotechnology company focusing on clinical stage pharmaceuticals was embarking on a journey to mature how it handles and manages information. Their goal is to provide access to the appropriate information to the appropriate stakeholders in a secure and readily accessible manner, however based on recent events there was increased urgency to mature the Information Asset Management (IAM) process to address the following challenges:
This company was experiencing significant growth in its information assets across a multitude of applications, both on-premises as well as in the cloud, compounding the challenges highlighted above. These large datasets had little-to-no management process for loss prevention, archiving or deletion, and data volumes were projected to double in the next 18-24 months.
The Information Asset Management initiative was part of a broader Information Management program. This initiative helped provide a view into information assets, allowing the company to identify and secure its vital information assets.
During this engagement, the Triverus team worked with four departments – Research and Development, Clinical, Technical Operations, and G&A – to gather information and document key findings. This analysis focused on the following four areas:
Based on analysis across these key areas, Triverus developed an actionable roadmap outlining recommendations and next steps to better protect and utilize data across the organization.
Triverus worked with this organization to develop a pragmatic, long-term roadmap to establish a sustainable IAM program. This plan factored in the organization’s current state, tolerance for risk, resource availability and overall urgency. This plan also factored in their Information Technology group’s go-forward system administration and management footprint.